20.40NOK-1.45%Mkt Cap: 1.03B NOKP/E: 77.31Last update: 2026-05-13
ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp a…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)77.31
P/E (Forward)31.96
PEG—
P/B3.46
P/S8.00
EV/EBITDA77.80
EV/Revenue7.86
EPS (TTM)0.26
EPS (Forward)0.63
Cash Flow & Leverage
FCF Yield-6.23%
FCF Margin-49.83%
Operating CF25.80M NOK
CapEx (TTM)3.64M NOK
Net Debt/EBITDA-12.90
Net Debt-167.28M NOK
Technical
SMA 5020.49 (-0.4%)
SMA 20023.35 (-12.6%)
Beta—
S&P 52W Chg24.23%
Avg Vol (30d)83.05K
Avg Vol (10d)101.36K
Technical Indicators
RSI (14)48.2
MACD0.0927
MACD Signal0.1738
MACD Hist.-0.0811
BB Upper23.06 NOK
BB Middle20.70 NOK
BB Lower18.34 NOK
BB Width22.76%
ATR (14)1.190 NOK
Vol Ratio (20d)0.28x
52W Range
15.0033% of range31.40
52W High31.40 NOK
52W Low15.00 NOK
Profitability
Gross Margin95.68%
EBITDA Margin10.10%
Profit Margin8.65%
Oper. Margin-2.15%
ROE2.88%
ROA2.70%
Revenue Growth40.90%
Earnings Growth—
Balance Sheet
Debt/Equity0.02
Current Ratio15.83
Quick Ratio15.05
Book Value/Sh5.817 NOK
Cash/Share3.187 NOK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 NOK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.51.07M
Float49.00M
Insiders17.51%
Institutions14.55%
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)31.00 NOK
Target Range28.00 NOK – 34.00 NOK
# Analysts2
Company
Market Cap1.03B NOK
Enterprise Value1.01B NOK
Revenue (TTM)128.37M NOK
Gross Profit107.75M NOK
Net Income (TTM)9.74M NOK
Revenue/Share2.392 NOK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees53
Last Price20.40 NOK
CountryNO
SectorHealthcare
IndustryBiotechnology
ISINNO0010014632